All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

MEDVi Alternative 2026

Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering.

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

MEDVi Alternative 2026 custom 2026 header image for Provider Comparisons
Custom header image for MEDVi Alternative 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: MEDVi Alternative 2026

Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering.

Short answer

Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering.

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering.

MEDVi has built a following in the GLP-1 telehealth space, and for good reason. Their platform connects patients with licensed providers, handles prescriptions, and ships compounded medications. It works for a lot of people.

But not everyone. Maybe you have been waiting too long for provider responses. Maybe the pricing doesn't fit your budget anymore. Maybe you want more hands-on clinical oversight or access to peptide therapies beyond semaglutide. Whatever brought you here, you aren't alone in looking for a MEDVi alternative in 2026.

We evaluated the leading telehealth GLP-1 programs across pricing, clinical care, medication options, and patient experience to help you find the right fit.

Why People Look for MEDVi Alternatives

MEDVi patients typically start exploring other options for a handful of recurring reasons:

  • Limited provider interaction. Some patients feel the consultations are too brief or infrequent for the complexity of GLP-1 therapy.
  • Pricing concerns. As patients titrate to higher doses, monthly costs can climb in ways they did not anticipate at enrollment.
  • Narrow medication options. Patients interested in tirzepatide, BPC-157, or other peptide therapies may find MEDVi's formulary limiting.
  • Customer service friction. Billing questions, shipping delays, and difficulty reaching support staff come up frequently in patient reviews.
  • Desire for more personalized protocols. Cookie-cutter dosing schedules don't work for everyone, and some patients want a provider who adjusts based on their individual response.

None of these issues mean MEDVi is a bad program. They mean it isn't the right program for everyone.

Top MEDVi Alternatives in 2026

1. FormBlends

FormBlends is a physician-supervised telehealth platform specializing in compounded GLP-1 and peptide therapy. What sets it apart from MEDVi is the depth of clinical engagement. Every patient works directly with a licensed physician who builds and adjusts their protocol based on individual response, lab work, and treatment goals.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for MEDVi Alternative 2026

The medication options are broader than most competitors. Beyond compounded semaglutide ($199/month) and tirzepatide ($249/month), FormBlends offers peptide therapies like BPC-157 for recovery and gut health. For patients who felt boxed in by MEDVi's formulary, that flexibility matters.

Pricing is transparent and all-inclusive. There are no hidden consult fees, no surprise charges at higher doses, and no long-term contracts.

Pros:

  • Direct physician supervision with personalized dosing
  • Broad formulary including GLP-1s and peptide therapies
  • Transparent, flat-rate monthly pricing
  • No long-term commitment required

Cons:

  • Not the cheapest option available
  • Newer brand with less mainstream recognition

2. Ro Body

Ro brings strong medical infrastructure to the GLP-1 space. Their in-house pharmacy and lab monitoring protocols give patients a clinical experience that goes beyond what most telehealth platforms provide. If your primary concern with MEDVi was the quality of medical oversight, Ro is worth evaluating.

Starting prices are competitive at $149/month for compounded semaglutide, though costs increase as you move to higher doses. The program is physician-led and data-driven, with dosing adjustments based on objective lab results rather than patient self-reporting alone.

Pros:

  • Lab monitoring included in the program
  • In-house pharmacy for quality control
  • Strong medical oversight

Cons:

  • Higher-dose pricing can add up
  • Not available in every state
  • No peptide therapy options

3. Henry Meds

If price is your primary reason for leaving MEDVi, Henry Meds deserves a look. At $149/month for compounded semaglutide with no separate consult fees, it's one of the most affordable physician-supervised GLP-1 programs available. The tradeoff is a more simplified (some would say basic) clinical experience.

Pros:

  • $149/month all-in pricing
  • Simple enrollment process
  • No hidden fees

Cons:

  • Less personalized medical oversight
  • No lab monitoring
  • Limited medication options

4. Hims/Hers

Hims (and its sister brand Hers) operates at massive scale, which translates to reliable supply chains and a polished user experience. For patients who left MEDVi due to shipping delays or platform usability issues, Hims offers a smoother day-to-day experience. Clinical depth isn't the strength here, but operational reliability is.

Pros:

  • Well-established platform with reliable logistics
  • Competitive pricing
  • Strong mobile app experience

Cons:

  • High-volume model means less individual attention
  • Limited peptide options
  • Provider interactions can feel transactional

5. SkinnyRx

SkinnyRx focuses specifically on weight loss medications and keeps its program lean. Pricing is competitive, the enrollment process is quick, and the platform doesn't try to be everything to everyone. If you want a focused GLP-1 program without the extras, SkinnyRx is a solid alternative.

Pros:

  • Focused exclusively on weight loss
  • Fast enrollment and shipping
  • Competitive pricing

Cons:

  • No peptide therapy options
  • Less clinical depth than physician-supervised programs
  • Smaller support team

MEDVi Alternatives Comparison Table

Program Monthly Cost Medications Physician Supervision Peptide Therapy Contracts
FormBlends $199+ Semaglutide, tirzepatide, peptides Direct physician oversight Yes None
Ro Body $149+ Semaglutide, tirzepatide Lab-based monitoring No None
Henry Meds $149 Semaglutide Monthly check-ins No None
Hims/Hers $149+ Semaglutide, tirzepatide Provider consultations No None
SkinnyRx $149+ Semaglutide Basic oversight No None

Who Should Consider Switching from MEDVi

Switching GLP-1 providers mid-treatment isn't something to do on a whim. If your current protocol is working and your side effects are manageable, stability has real value. But certain situations make a switch worth considering:

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →
  • You want more clinical involvement. If you feel like your MEDVi provider isn't adjusting your protocol based on how you're actually responding, a program with deeper physician engagement (like FormBlends or Ro) may produce better outcomes.
  • You need peptide therapy options. If you're interested in BPC-157 or other therapeutic peptides alongside your GLP-1, you'll need a provider with a broader formulary.
  • The cost isn't sustainable. If your monthly spend has climbed beyond what you budgeted, programs like Henry Meds offer similar medication at lower price points.
  • You're having service issues. Chronic shipping delays, billing errors, or difficulty reaching support are legitimate reasons to move your care elsewhere.

Frequently Asked Questions

Can I switch from MEDVi to another provider without a gap in treatment?

Yes, in most cases. The best approach is to enroll with your new provider before your current MEDVi prescription runs out. Most telehealth GLP-1 programs can get you started within a few days of your initial consultation, so there should be minimal or no gap in your medication.

Will I need to start over at a low dose if I switch providers?

Not necessarily. A good provider will review your treatment history and continue from your current dose if it's appropriate. Be prepared to share your dosing history and any relevant lab work with your new provider.

Are compounded GLP-1 medications the same across providers?

Compounded medications can vary by pharmacy. Different providers work with different 503B compounding pharmacies, and quality standards, formulations, and concentrations may differ. Programs that work with FDA-registered compounding facilities and maintain strong pharmacy relationships tend to deliver more consistent results.

Is it safe to switch GLP-1 providers?

Switching providers is safe as long as your new physician has a complete picture of your treatment history. The medication itself doesn't change. what changes is the clinical team managing your care. If anything, moving to a provider with better oversight can improve your safety profile.

Do I need to cancel MEDVi before signing up elsewhere?

You should cancel your MEDVi subscription to avoid being billed, but you don't need to cancel before enrolling with a new provider. Start the new program first, confirm your medication is on the way, and then cancel MEDVi to avoid a gap.

Key Points

MEDVi works for many patients, but the GLP-1 telehealth market in 2026 offers enough strong alternatives that you don't have to settle for a program that isn't meeting your needs. Whether you prioritize cost, clinical depth, or access to peptide therapies, there's a program built for what you're looking for.

Ready to explore a physician-supervised alternative? FormBlends offers personalized GLP-1 and peptide therapy with direct physician oversight, transparent pricing, and no long-term contracts. Start your consultation today.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Henry Meds official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For MEDVi Alternative 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

MEDVi Alternative 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Looking for a MEDVi alternative in 2026? We compare the top physician-supervised GLP-1 and peptide therapy programs worth considering. "MEDVi Alternative 2026" works best as a practical checklist for the next conversation. It focuses on comparison and decision support, then narrows the issue through the main claim, safety boundary, and next practical step. With 6 sections, the FAQ can reveal what readers usually miss. Use the page to prepare, then verify the personal medical pieces with a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for MEDVi Alternative 2026

MEDVi Alternative 2026 now carries extra 2026 context around semaglutide, tirzepatide, BPC-157, cash-pay pricing, safety signals, medvi, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.

Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to medvi alternative 2026.

Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.

MEDVi Alternative 2026 custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for MEDVi Alternative 2026, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering MEDVi Alternative 2026, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.